ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2017 American Transplant Congress

    Race, Admissions, and Renal Transplant Waitlisting.

    R. Lynch, R. Zhang, R. Patzer, C. Larsen, A. Adams.

    Surgery, Emory University, Atlanta, GA

    Background: We have previously shown that increased hospitalization while listed for renal transplantation is associated with excess waitlist mortality, reduced odds of transplantation, and inferior…
  • 2017 American Transplant Congress

    Kidney Transplant Rejection Associated with DQ Eplet Mismatches.

    S. Chakola,1 P. Warner,2 N. Andeen,3 B. Najafian,3 N. Leca,1 C. Blosser.1

    1Medicine, University of Washington, Seattle, WA; 2Bloodworks Northwest, Seattle, WA; 3Pathology, University of Washington, Seattle, WA

    The presence of anti-HLA antibodies is associated with acute rejection, allograft dysfunction and earlier graft loss. HLA antibodies are recognized as being specific to these…
  • 2017 American Transplant Congress

    Graft Survival in De Novo Donor-Specific Antibodies and Positive Flow Crossmatch Kidney Transplants Is influenced by Class I and Class II.

    S. Montag,1,2 B. Ho,1 H. Bhagat,3 E. Lee,3,4 K. Atiemo,1 A. Daud,1 R. Kang,1 L. Zhao,1,2 J. Schwartz,3 D. Ladner.1

    1Northwestern University Transplant and Outcomes Research Collaborative (NUTORC), Chicago; 2Dept of Preventive Medicine, Northwestern University, Chicago; 3Astellas Pharma Global Development, Northbrook; 4Now with UCB, Atlanta

    Patients with de novo donor-specific antibodies (dnDSA) show inferior graft survival in numerous small studies. We assessed the effect of dnDSA on graft and patient…
  • 2017 American Transplant Congress

    Compartmental Infiltration of Kidney Allograft with Monocyte-Macrophage Subtypes Defines the Type of Rejection.

    T. van den Bosch,1 M. Clahsen-van Groningen,2 F. Rezaee,3 D. Hesselink,1 D. Nieboer,4 E. Steyerberg,4 C. Baan,1 A. Rowshani.1

    1Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands; 2Pathology, Erasmus University Medical Center, Rotterdam, Netherlands; 3Gastroenterology, Erasmus University Medical Center, Rotterdam, Netherlands; 4Public Health, Erasmus University Medical Center, Rotterdam, Netherlands

    Purpose: Rejection significantly worsens the graft function and survival. We studied monocyte-macrophage compartmental infiltration of 62 kidney transplant biopsies with diagnosis of: acute antibody mediated…
  • 2017 American Transplant Congress

    Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.

    N. Lam,1 A. Garg,2 G. Knoll,3 J. Kim,4 K. Lentine,5 E. McArthur,6 K. Naylor,6 S. Bota,6 M. Sood.3

    1University of Alberta, Edmonton, Canada; 2Western University, London, Canada; 3University of Ottawa, Ottawa, Canada; 4University of Toronto, Toronto, Canada; 5Saint Louis University School of Medicine, St. Louis; 6Institute for Clinical Evaluative Sciences, London, Canada

    Background: The incidence of venous thromboembolism (VTE) in kidney transplant recipients varies widely in the literature. The implications of VTE for morbidity and mortality in…
  • 2017 American Transplant Congress

    Induction of Delayed Renal Allograft Tolerance Using Only Clinically Available Reagents in Non-Human Primates.

    K. Hotta, T. Oura, A. Dehnadi, S. Boskovic, M. Matsunami, I. Rosales, N. Smith, R. Colvin, A. Cosimi, T. Kawai.

    Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA

    Background: We have previously reported successful induction of renal allograft tolerance following a period of conventional immunosuppression (Delayed tolerance) using nonmyeloablative conditioning that included anti-CD154…
  • 2017 American Transplant Congress

    Increased Long-Term Mortality 20 years After Living Kidney Donation.

    G. Mjoen,1 S. Hallan,2 H. Holdaas.1

    1Dpt of Transplantation, Rikshospitalet, Oslo, Norway; 2Dpt of Nephrology, St. Olavs Hospital, Trondheim, Norway

    Living kidney donors are healthy at the time of donation. Consequently, a long observation period is necessary to detect possible detrimental effects of donation. Most…
  • 2017 American Transplant Congress

    Safety and Activity of Anti-C1s Humanized Monoclonal Antibody TNT009 in Late Antibody-Mediated Kidney Allograft Rejection – Results of a First-in-Human Phase 1 Trial.

    F. Eskandary,1 B. Jilma,2 J. Muehlbacher,3 M. Wahrmann,1 H. Regele,4 N. Kozakowski,4 S. Panicker,5 J. Reeve,6 P. Halloran,6 J. Gilbert,5 G. Bohmig.1

    1Department of Medicine III, Medical University Vienna, Vienna, Austria; 2Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria; 3Department of Surgery, Medical University Vienna, Vienna, Austria; 4Department of Clinical Pathology, Medical University Vienna, Vienna, Austria; 5True North Therapeutics Inc., San Frnacisco; 6Alberta Transplant Applied Genomics Centre, University of Alberta, Edmonton, Canada

    Study purpose:The classical pathway (CP) of complement may significantly contribute to antibody-mediated rejection (ABMR). Blockade of CP key component C1 may be a promising strategy…
  • 2017 American Transplant Congress

    Donor Warm Ischemic Time >80min Is an Important Predictor of Kidney Graft Survival from Donors After Cardiac Death.

    J. Chen,1 D. Mikhail,2 H. Sharma,3 A. Hijazi,1 D. Nap,1 L. Stitt,4 J. Jevnikar,5 M. Cooper,6 P. Luke,2 A. Sener.2

    1Schulich School of Medicine & Dentistry, London, Canada; 2Urology, Western University, London, Canada; 3General Surgery, Western University, London, Canada; 4LW Stitt Statistical Services, London, Canada; 5Engineering, Ryerson University, Toronto, Canada; 6Georgetown University, Washington

    We analyzed UNOS data to determine how donor warm ischemic time (WIT), donor BMI, donor hypertension (dHTN), cold ischemic time (CIT), and vasopressin use in…
  • 2017 American Transplant Congress

    Simple Kidney Transplant Graft Survival (KTGS) Calculator Predicts 5- and 10-Year Allograft Survival.

    P. Sood,1 W. Cherikh,2 R. Mehta,1 A. Tevar,1 S. Hariharan.1

    1Transplant, University of Pittsburgh, Pittsburgh; 2Research Department, United Network for Organ Sharing, Richmond

    To develop a predictive 5- and 10-year Kidney Transplant Graft Survival (KTGS) calculator at the time of transplant for living donor (LD) and deceased (DD)…
  • « Previous Page
  • 1
  • …
  • 339
  • 340
  • 341
  • 342
  • 343
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences